海波重科 reported revenue of ¥0.08B for the period ended 2026-06-30, -48.5% year on year. Net income was ¥-0.01B, a -9.9% net margin on a 10.8% gross margin. The largest revenue line is 钢结构工程 at 99% of the total.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.08B | -48.5% |
| Gross profit | ¥0.01B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | -325.6% |
| Gross margin | 10.8% | Net margin -9.9% |
| Revenue Q/Q | +12.1% | — |
| Segment | Revenue | Share |
|---|---|---|
| 钢结构工程 | ¥0.08B | 99.3% |
| 其他收入 | ¥0.00B | 0.7% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.07B | 89.2% |
| R&D | ¥0.00B | 3.8% |
| SG&A | ¥0.01B | 9.6% |
| Tax & other | ¥-0.01B | -6.4% |
| Item | Amount |
|---|---|
| Total assets | ¥1.43B |
| Total liabilities | ¥0.40B |
| Shareholders' equity | ¥1.04B |
| Equity / assets | 72.4% |
| Operating cash flow | ¥0.05B |
| Cash conversion (OCF / net income) | -1283% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
新迅达 ・ 新光药业 ・ 科大国创 ・ 爱司凯 ・ 世名科技 ・ 辰安科技 ・ 博思软件 ・ ST应急 ・ 幸福蓝海 ・ 健帆生物 ・ 领湃科技 ・ 优博讯
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies